Peritoneal Carcinomatosis: A Multidisciplinary Approach (eBook, PDF)
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Peritoneal Carcinomatosis: A Multidisciplinary Approach (eBook, PDF)
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
- Geräte: PC
- eBook Hilfe
Andere Kunden interessierten sich auch für
Produktdetails
- Produktdetails
- Verlag: Springer US
- Erscheinungstermin: 6. März 2007
- Englisch
- ISBN-13: 9780387489933
- Artikelnr.: 37287133
- Verlag: Springer US
- Erscheinungstermin: 6. März 2007
- Englisch
- ISBN-13: 9780387489933
- Artikelnr.: 37287133
Wim P. Ceelen, University Hospital, Ghent, Belgium
Peritoneal Carcinomatosis: Basic Concepts.- Structure and Function of Mesothelial Cells.- Molecular Biology of Peritoneal Carcinomatosis.- Role of Adhesion Molecules in Locoregional Cancer Spread.- Surgical Trauma, Minimal Residual Disease and Locoregional Cancer Recurrence.- Pseudomyxoma Peritonei Syndrome: Classification of Appendiceal Mucinous Tumours.- The Pathogenesis of Malignant Ascites.- Natural History of Peritoneal Carcinomatosis from Digestive Origin.- The Rationale for Intraperitoneal Heat and Drug Therapy.- Intraperitoneal Drug Therapy: Physical and Biological Principles.- Current Status of Intraperitoneal Antineoplastic Drug Delivery.- The Biologic Rationale of Hyperthermia.- Interactions between Hyperthermia and Cytotoxic Drugs.- Pharmacodynamic Aspects of Intraperitoneal Cytotoxic Therapy.- Cytoreductive Surgery for Peritoneal Carcinomatosis: Techniques and Methods.- Patient Selection for Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion.- Staging and Scoring of Peritoneal Carcinomatosis.- Peritonectomy Procedures.- Continuous Peritoneal Perfusion: Techniques, Methods and Applications.- Handling of Chemotherapeutic Drugs in the OR: Hazards and Safety Considerations.- Clinical Results of Surgery with or without Intraperitoneal Heated Drug Therapy.- Results of Cytoreduction followed by HIPEC in Carcinomatosis of Colorectal Origin.- HIPEC with Oxaliplatin in the Treatment of Peritoneal Carcinomatosis of Colorectal Origin.- Clinical Results of Cytoreduction and HIPEC in Pseudomyxoma Peritonei.- The Impact of Therapy in the Treatment of Pseudomyxoma Peritonei.- Clinical Results of Cytoreduction and HIPEC for Malignant Peritoneal Mesothelioma.- Cytoreduction and Intraperitoneal Chemotherapy for Carcinomatosis from Gastric Cancer.- Cytoreduction andIntraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Cancer.- The role of Neoadjuvant Chemotherapy versus Primary Surgery in the Management of Stage III Ovarian Cancer.- Morbidity and Quality of Life following Cytoreduction and HIPEC.- Detection and Treatment of Recurrent Disease after Cytoreduction and HIPEC.- Nonoperative and Multimodal Management of Peritoneal Carcinomatosis.- Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer.- Systemic Chemotherapy in patients with Peritoneal Carcinomatosis from Non Colorectal Origin.- The Role of Radiotherapy in the treatment of Peritoneal Carcinomatosis.- Medical and Palliative Management of Malignant Ascites.- Experimental Approaches.- Targeted Intraabdominal Chemotherapy for Peritoneal Carcinomatosis.- Immunotherapy of Peritoneal Carcinomatosis.- Intraperitoneal Photodynamic Therapy.- Intraperitoneal Gene Therapy.
Peritoneal Carcinomatosis: Basic Concepts.- Structure and Function of Mesothelial Cells.- Molecular Biology of Peritoneal Carcinomatosis.- Role of Adhesion Molecules in Locoregional Cancer Spread.- Surgical Trauma, Minimal Residual Disease and Locoregional Cancer Recurrence.- Pseudomyxoma Peritonei Syndrome: Classification of Appendiceal Mucinous Tumours.- The Pathogenesis of Malignant Ascites.- Natural History of Peritoneal Carcinomatosis from Digestive Origin.- The Rationale for Intraperitoneal Heat and Drug Therapy.- Intraperitoneal Drug Therapy: Physical and Biological Principles.- Current Status of Intraperitoneal Antineoplastic Drug Delivery.- The Biologic Rationale of Hyperthermia.- Interactions between Hyperthermia and Cytotoxic Drugs.- Pharmacodynamic Aspects of Intraperitoneal Cytotoxic Therapy.- Cytoreductive Surgery for Peritoneal Carcinomatosis: Techniques and Methods.- Patient Selection for Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion.- Staging and Scoring of Peritoneal Carcinomatosis.- Peritonectomy Procedures.- Continuous Peritoneal Perfusion: Techniques, Methods and Applications.- Handling of Chemotherapeutic Drugs in the OR: Hazards and Safety Considerations.- Clinical Results of Surgery with or without Intraperitoneal Heated Drug Therapy.- Results of Cytoreduction followed by HIPEC in Carcinomatosis of Colorectal Origin.- HIPEC with Oxaliplatin in the Treatment of Peritoneal Carcinomatosis of Colorectal Origin.- Clinical Results of Cytoreduction and HIPEC in Pseudomyxoma Peritonei.- The Impact of Therapy in the Treatment of Pseudomyxoma Peritonei.- Clinical Results of Cytoreduction and HIPEC for Malignant Peritoneal Mesothelioma.- Cytoreduction and Intraperitoneal Chemotherapy for Carcinomatosis from Gastric Cancer.- Cytoreduction andIntraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Cancer.- The role of Neoadjuvant Chemotherapy versus Primary Surgery in the Management of Stage III Ovarian Cancer.- Morbidity and Quality of Life following Cytoreduction and HIPEC.- Detection and Treatment of Recurrent Disease after Cytoreduction and HIPEC.- Nonoperative and Multimodal Management of Peritoneal Carcinomatosis.- Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer.- Systemic Chemotherapy in patients with Peritoneal Carcinomatosis from Non Colorectal Origin.- The Role of Radiotherapy in the treatment of Peritoneal Carcinomatosis.- Medical and Palliative Management of Malignant Ascites.- Experimental Approaches.- Targeted Intraabdominal Chemotherapy for Peritoneal Carcinomatosis.- Immunotherapy of Peritoneal Carcinomatosis.- Intraperitoneal Photodynamic Therapy.- Intraperitoneal Gene Therapy.